Results 91 to 100 of about 31,703 (224)

Interpretative Phenomenological Study Exploring Why People With Kidney Failure Say ‘No’ to a Kidney Transplant

Journal of Advanced Nursing, Volume 82, Issue 6, Page 6602-6621, June 2026.
ABSTRACT Aim To develop an in‐depth understanding of peoples' perceptions and experiences of decision‐making and reasons why they declined the opportunity of a kidney transplant. Design The Theory of Planned Behaviour informed the qualitative interpretative phenomenological analysis. Methods Semi‐structured interviews were conducted between August 2022
Emma Jones, Leah McLaughlin, Kate Shakespeare, Jane Noyes   +3 more
wiley   +1 more source

Primary IgA-Nephropathy [PDF]

, 1986
In the introduction of this thesis basic motives and assumptions are stated. In chapter I data from literature on IGA-Nephropathy upto December 1983 are reviewed. A heuristic system of work-hypotheses concerning mesangial IgAdeposition is developed. Some
Beukhof, Johan Richard, Beukhof, Johan Richard,   +1 more
core  

Current status of clinical studies of IgA nephropathy with minimal proteinuria

Linchuang shenzangbing zazhi, 2020
Patients with IgA nephropathy with minimal proteinuria(proteinuria
SHI Yu-zhen, DONG Li-ting, ZHU Min-min, MA Zhi-gang   +3 more
doaj  

Late Presentation of de Novo Proliferative Glomerulonephritis With Monoclonal IgG Deposits in a Renal Allograft: A Rare Case With an Unusual Clinical Course

Nephrology, Volume 31, Issue 6, June 2026.
ABSTRACT Proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID) is a form of monoclonal gammopathy of renal significance (MGRS) in which monoclonal immunoglobulin deposits are found within the glomerulus, without involvement of other renal compartments.
Hayley J. Duxbury, David A. Brown, Adrian Y. S. Lee, Germaine Wong, Fiona Kwok, Seethalakshmi Viswanathan   +5 more
wiley   +1 more source

Primary IgA nephropathy: current challenges and future prospects

, 2018
Rose S Penfold, Maria Prendecki, Stephen McAdoo, Frederick WK Tam Renal and Vascular Inflammation Section, Department of Medicine, Imperial College London, London, UK Abstract: IgA nephropathy (IgAN) is the most common form of primary ...
Prendecki M, Tam FWK, Penfold RS, McAdoo S   +3 more
core  

Adalimumab-induced IgA nephropathy

, 2019
Immunoglobulin A nephropathy (IgAN) is the most commonly diagnosed glomerulonephritis worldwide. It is usually idiopathic and may be associated with many other diseases. Recently, biological agents including tumour necrosis factor alpha (TNFα) inhibitors
Wilson, GJ, Ranganathan, D, Singh, AKB, Jeyaruban, AS   +3 more
core   +1 more source

Emerging Modes of Treatment of IgA Nephropathy

, 2020
IgA nephropathy is the most common primary glomerulonephritis with potentially serious outcome leading to end stage renal disease in 30 to 50% of patients within 20 to 30 years.
Vladimir Tesar, Dita Maixnerova
core   +1 more source

IgA in IgA nephropathy.

, 1992
IgA in IgA Nephropathy Lorna Layward IgA nephropathy is a common glomerulonephritis of unknown pathogenesis, characterised by the presence of IgA within the glomerular mesangium.
Lorna. Layward (7628906)
core  

Correlation of immunostaining findings with demographic data and variables of Oxford classification in IgA nephropathy [PDF]

, 2013
Background: Oxford classification for IgA nephropathy (IgAN) did not include pattern of immunostaining in the analysis. Objective: The aim of this study is to determine the potential correlation between the immunostaining data and morphologic variables ...
Ali momeni, Madihi, Yahya., Emami Naieni, Afsoon., Alireza Merikhi, Alaleh Ghiessari, Afsoon Emami Naieni, Merikhi, Alireza., Hamid Nasri, Yahya Madihi, Mardani, Saeed., Nasri, Hamid., Sajjadieh, Shahram., Gheissari, Alaleh., Saeed Mardani, Shahram Sajjadieh, Momeni, Ali.   +15 more
core   +1 more source

Sparsentan in IgA nephropathy: a plain language summary of publication for the PROTECT study

Therapeutic Advances in Rare Disease
Summary What is this summary about? Sparsentan (FILSPARI ® ) is a once-daily pill for people with Immunoglobulin A (IgA) nephropathy who are at high risk for worsening kidney disease.
Brad H. Rovin, Radko Komers, Chris Scroggins, Jonathan Barratt   +3 more
doaj   +1 more source